TI
TECH icon

Trigran Investments’s Bio-Techne TECH Stock Holding History

Trigran Investments’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-174,200
Closed -$3.49M – 24
2013
Q3 		$3.49M Hold
174,200
– – 1.65% 18
2013
Q2 		$3.01M Buy
+174,200
New +$2.89M 1.49% 18

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Trigran Investments's TECH Position: Q4 2013 in Review

Trigran Investments sold out of Bio-Techne (TECH) in Q4 2013, closing a stake of 174,200 shares — an estimated $3.49M sold.

Trigran Investments first reported a position in TECH in Q2 2013 and held it in 2 quarters. The position peaked at $3.49M in Q3 2013. 245 funds tracked by Wall St. Rank hold TECH as of Q4 2013.

  • Trigran Investments reported no remaining Bio-Techne position as of Q4 2013 after selling out during the quarter.
  • Trigran Investments sold 174,200 Bio-Techne shares in Q4 2013, an estimated $3.49M.
  • Trigran Investments first reported a position in Bio-Techne in Q2 2013 and held it in 2 quarters.
  • Trigran Investments's Bio-Techne position peaked at $3.49M in Q3 2013.
  • 245 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2013.

Based on Trigran Investments's 13F filing for Q4 2013, filed 6 Feb 2014.